A patient with glomerulonephritis is experiencing increased edema and elevated blood pressure despite current antihypertensive therapy. Laboratory findings show elevated serum creatinine and significant proteinuria. What is the most appropriate initial nursing intervention to address the patient's fluid overload?

C) Implement a low-sodium diet to help manage fluid retention.

A) Encourage the patient to increase fluid intake to flush out the kidneys.

B) Elevate the patient's legs while sitting to reduce peripheral edema.

C) Implement a low-sodium diet to help manage fluid retention.

D) Discontinue the patient's antihypertensive medication until renal function improves.

A nurse is reviewing the lab results of a patient with glomerulonephritis who has persistent hypertension and worsening edema. Which of the following interventions should the nurse anticipate as part of the revised management plan?

C) Referral to a nephrologist for potential immunosuppressive therapy

A) Initiation of a low-protein diet to reduce kidney workload

B) Increase in antihypertensive medication dosage without changing the regimen

C) Referral to a nephrologist for potential immunosuppressive therapy

D) Discontinuation of current antihypertensive medications

A patient with hypertension and renal impairment has been started on a diuretic, leading to hypokalemia. Which intervention should the nurse prioritize to address the patient's current electrolyte imbalance?

A) Administer a potassium supplement as prescribed

B) Encourage the patient to increase fluid intake

C) Recommend a low-potassium diet

D) Monitor the patient's blood pressure every 2 hours

A patient with a history of hypertension and recent addition of a diuretic to her treatment regimen presents with muscle cramps, increased weakness, palpitations, and a heart rate of 104 bpm. Laboratory results show hypokalemia and a slight rise in serum creatinine. Which nursing intervention should take priority to address the patient's current condition?

C) Administer prescribed potassium supplements and monitor serum electrolyte levels closely

A) Encourage increased oral fluid intake to improve renal function

B) Educate the patient on dietary sources of potassium to prevent hypokalemia

C) Administer prescribed potassium supplements and monitor serum electrolyte levels closely

D) Initiate a low-sodium diet to manage hypertension and reduce edema

A patient with glomerulonephritis is experiencing a decline in renal function, as evidenced by increased serum creatinine and proteinuria. The healthcare team considers transitioning to a more aggressive immunosuppressive therapy. Which nursing intervention is most appropriate to prioritize in this scenario to ensure patient safety?

A) Monitor the patient's blood pressure closely and report any significant changes to the healthcare provider.

B) Educate the patient and family about the potential side effects of the new medication regimen.

C) Schedule regular laboratory tests to monitor electrolyte levels and renal function.

D) Encourage the patient to increase fluid intake to dilute urinary protein levels.

A patient with a diagnosis of glomerulonephritis presents with increased lethargy, mild confusion, elevated serum creatinine, and significant proteinuria. The healthcare team is considering a change in treatment strategy to address these symptoms. As the nurse, what is the most important intervention to prioritize during this period?

A) Monitor the patient's blood pressure closely and report any significant changes to the physician.

B) Educate the patient and family about dietary restrictions related to sodium and protein intake.

C) Ensure the patient maintains adequate hydration to support renal function.

D) Prepare the patient for a potential renal biopsy by explaining the procedure and obtaining informed consent.

A patient with focal segmental glomerulosclerosis (FSGS) is being treated with tacrolimus and an angiotensin receptor blocker (ARB). Which nursing intervention is most important to prioritize in the care of this patient?

C) Assess for signs of nephrotoxicity by monitoring renal function tests.

A) Monitor for signs of infection due to immunosuppression.

B) Educate the patient on dietary modifications to reduce potassium intake.

C) Assess for signs of nephrotoxicity by monitoring renal function tests.

D) Encourage increased fluid intake to prevent dehydration.

A patient with newly diagnosed focal segmental glomerulosclerosis (FSGS) is started on tacrolimus and an angiotensin receptor blocker (ARB). Which laboratory finding would be most concerning to the nurse monitoring this patient?

C) Serum potassium level of 5.8 mEq/L

A) Serum creatinine level of 2.2 mg/dL

B) Blood pressure of 138/88 mmHg

C) Serum potassium level of 5.8 mEq/L

D) Urinary protein excretion of 500 mg/day

A patient with glomerulonephritis has been experiencing increased fatigue, mild swelling in the lower extremities, and elevated serum creatinine and potassium levels. Given these findings, what is the priority nursing intervention?

C) Monitor the patient's blood pressure closely and adjust medications as needed

A) Educate the patient on the importance of maintaining a low-protein diet

B) Instruct the patient to increase fluid intake to promote kidney function

C) Monitor the patient's blood pressure closely and adjust medications as needed

D) Encourage the patient to increase dietary potassium to support muscle function

A patient with a history of glomerulonephritis is experiencing increased fatigue, mild lower extremity swelling, and recent lab results show serum creatinine at 2.5 mg/dL and potassium at 5.6 mEq/L. The healthcare team is considering adjusting the patient's medication regimen. Which nursing intervention is most appropriate to prioritize in this scenario?

A) Educate the patient on reducing dietary potassium intake.

B) Encourage the patient to increase fluid intake to dilute serum potassium.

C) Suggest the patient increase protein intake to manage proteinuria.

D) Advise the patient to monitor blood pressure daily and report significant changes.

Glomerulonephritis - Nursing Case Study

Pathophysiology

• Primary mechanism: Immune complex deposition - In glomerulonephritis, immune complexes form due to antigen-antibody reactions and deposit in the glomerular basement membrane, triggering inflammation and damage. This leads to increased permeability and impaired filtration.

• Secondary mechanism: Complement activation - The deposited immune complexes activate the complement system, a part of the immune response that further exacerbates inflammation by attracting inflammatory cells and releasing cytokines, causing further injury to the glomerular structure.

• Key complication: Proteinuria and hematuria - Due to increased glomerular permeability, proteins and red blood cells leak into the urine, leading to proteinuria and hematuria, which are significant markers of kidney damage and impaired function.

Patient Profile

Demographics:

42-year-old female, school teacher

History:

• Key past medical history: Hypertension diagnosed 8 years ago, type 2 diabetes diagnosed 5 years ago

• Current medications: Lisinopril 20 mg daily, Metformin 500 mg twice daily, Atorvastatin 10 mg daily

• Allergies: Penicillin (rash)

Current Presentation:

• Chief complaint: Swelling and fatigue

• Key symptoms: Edema in lower extremities, hematuria, foamy urine, fatigue, decreased urine output

• Vital signs: Blood pressure 160/100 mmHg, heart rate 92 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F, oxygen saturation 96% on room air

Section 1

During the initial assessment, the nurse observes that the patient's edema has progressed, now extending from the lower extremities to the hands and face, indicating worsening fluid retention. The patient's blood pressure remains elevated at 162/102 mmHg despite being on antihypertensive medication, suggesting that her current treatment regimen may not be adequately controlling her hypertension. This uncontrolled blood pressure could exacerbate kidney damage and promote progression of the glomerulonephritis. The patient's heart rate is slightly increased at 94 bpm, and she reports feeling more fatigued than usual, with difficulty concentrating at work, which may be related to the expanding fluid overload and potential electrolyte imbalances.

To further evaluate the kidney function and the extent of the disease, the healthcare team orders a comprehensive metabolic panel and a urinalysis. The laboratory results reveal elevated serum creatinine at 2.1 mg/dL (normal range: 0.6-1.2 mg/dL), indicating a decline in kidney function compared to previous records. Blood urea nitrogen (BUN) is also elevated at 32 mg/dL (normal range: 7-20 mg/dL), supporting the diagnosis of acute kidney injury secondary to glomerulonephritis. The urinalysis confirms significant proteinuria with a protein level of 3+ and persistent hematuria. Microscopic examination of the urine shows red blood cell casts, which are indicative of glomerular inflammation and damage.

These findings prompt the healthcare team to consider adjustments to the patient's current management plan. Given the increased proteinuria and declining renal function, the nephrologist is consulted to evaluate the possibility of initiating immunosuppressive therapy to address the underlying immune-mediated damage. Additionally, adjustments to her antihypertensive regimen are considered to achieve better blood pressure control, potentially including the addition of a diuretic to manage the fluid overload and alleviate some of her symptoms. These interventions aim to stabilize the patient's condition and prevent further complications, but require close monitoring for potential side effects and effectiveness.

Section 2

Several days after adjusting the patient's management plan, the healthcare team observes a change in her status that necessitates further evaluation. The addition of a diuretic to her antihypertensive regimen initially seemed promising; her blood pressure decreased to 148/96 mmHg, and she reported a slight reduction in facial edema. However, during a follow-up visit, the nurse notes new complications. The patient now presents with muscle cramps and increased weakness. Her heart rate has risen to 104 bpm, and she is experiencing palpitations, suggesting possible electrolyte imbalance secondary to diuretic use.

To investigate these symptoms, repeat laboratory tests are performed. The results reveal hypokalemia, with a serum potassium level of 3.1 mEq/L (normal range: 3.5-5.0 mEq/L), likely due to increased renal excretion of potassium. In addition, her serum creatinine has risen slightly to 2.3 mg/dL, indicating persistent renal stress. The healthcare team also notes a marginal increase in proteinuria, suggesting ongoing glomerular damage despite initial treatment efforts. These findings prompt a reassessment of her medication regimen, particularly the need for potassium supplementation or a change to a potassium-sparing diuretic.

The nephrologist reviews the patient's current treatment and recommends adding a potassium supplement to stabilize her electrolyte levels. Close monitoring of her renal function and electrolyte status is emphasized to prevent further complications. The team also considers the need for a biopsy to better understand the underlying pathology and refine her immunosuppressive therapy. As the patient continues to experience fatigue and difficulty concentrating, a plan for more frequent follow-up visits is established to ensure timely intervention and adjustment of her treatment plan as needed. This comprehensive approach aims to address her current symptoms and mitigate the risk of further renal deterioration.

Section 3

As the healthcare team implements the recommended potassium supplementation, the patient's condition is closely monitored. Within a week, her serum potassium levels improve to 3.8 mEq/L, and she reports a reduction in muscle cramps and palpitations. However, during a routine check-up, the nurse notices that the patient exhibits increased lethargy and mild confusion, prompting further investigation. Vital signs reveal a blood pressure of 150/94 mmHg and a heart rate of 96 bpm, while her respiratory rate remains stable at 18 breaths per minute. Given these new symptoms, the physician orders additional laboratory tests to assess her overall metabolic status.

The new diagnostic results reveal a concerning increase in serum creatinine to 2.6 mg/dL, suggesting a further decline in renal function. Additionally, there is a noticeable increase in proteinuria, now quantified at 4.5 grams per day, indicating significant glomerular damage. Serum sodium levels are slightly reduced at 134 mEq/L (normal range: 135-145 mEq/L), raising concerns about possible fluid imbalances. These findings suggest that despite initial stabilization of electrolyte levels, the underlying glomerulonephritis is progressing, warranting prompt intervention.

In response to these developments, the healthcare team deliberates over potential changes to the patient's treatment regimen. The nephrologist considers transitioning to a more aggressive immunosuppressive strategy, possibly incorporating a calcineurin inhibitor or an angiotensin receptor blocker to better address the ongoing proteinuria and renal stress. Additionally, the possibility of performing a renal biopsy is revisited to gain deeper insight into the specific pathology driving her deteriorating condition. These steps are crucial in tailoring a more effective treatment plan and preventing further renal compromise. The patient and her family are involved in these discussions to ensure informed decision-making and adherence to the proposed management plan.

Section 4

As the healthcare team deliberates over the patient's treatment plan, they decide to proceed with a renal biopsy to gain a more comprehensive understanding of the underlying pathology causing her worsening condition. The biopsy results reveal focal segmental glomerulosclerosis (FSGS), a type of glomerular disease characterized by scarring in the kidneys, which aligns with the observed proteinuria and decline in renal function. This diagnosis provides clarity on why the patient's condition did not improve as expected with the initial treatment regimen.

In light of the new findings, the nephrologist recommends initiating a treatment plan incorporating a calcineurin inhibitor, such as tacrolimus, to help reduce proteinuria and stabilize renal function. Additionally, an angiotensin receptor blocker (ARB) is prescribed to manage hypertension and further protect the kidneys from damage. The patient is educated about the potential side effects of these medications, including the need for regular monitoring of blood pressure and renal function tests to assess response and detect any adverse effects early.

Over the following weeks, the patient's response to the adjusted treatment regimen is closely monitored. While her proteinuria shows a slight reduction, her blood pressure stabilizes at an improved reading of 138/88 mmHg, and her serum creatinine levels decrease to 2.2 mg/dL, indicating a positive response to the new therapeutic approach. However, the healthcare team remains vigilant for any signs of new complications, such as nephrotoxicity from the calcineurin inhibitor or further electrolyte imbalances, to ensure prompt intervention and ongoing management of her glomerulonephritis.

Section 5

As the weeks progress, the healthcare team notices a change in the patient's status that warrants further investigation. During a routine follow-up visit, the patient reports experiencing increased fatigue and mild swelling in her lower extremities, which she did not notice previously. Concerned about the potential for worsening renal function or other complications, the team conducts a comprehensive assessment and orders additional laboratory tests.

The new lab results reveal a slight increase in serum creatinine levels to 2.5 mg/dL and a concerning rise in potassium levels to 5.6 mEq/L, indicating hyperkalemia, likely related to the use of the ARB. Additionally, a urinalysis shows persistent proteinuria but no signs of new infection. Vital signs reveal a slightly elevated blood pressure of 142/92 mmHg, despite adherence to the prescribed medications. These findings suggest that while the treatment regimen initially showed promise, adjustments are necessary to address the emerging complications.

In response to these changes, the healthcare team decides to temporarily reduce the dose of the calcineurin inhibitor, tacrolimus, and reassess the patient's use of the ARB, considering an alternative antihypertensive that may have a less pronounced effect on serum potassium levels. The patient is counseled on dietary modifications to help manage her potassium levels and is scheduled for more frequent follow-up appointments to closely monitor her renal function and electrolyte balance. The team remains focused on optimizing the treatment plan to prevent further deterioration and manage the complexities of her glomerulonephritis effectively.